Literature DB >> 3188159

Serological diagnosis of neurocysticercosis: evaluation of ELISA tests using cyst fluid and other components of Taenia solium cysticerci as antigens.

G G Baily1, P R Mason, F E Trijssenar, N F Lyons.   

Abstract

An ELISA system was developed to assist with the diagnosis of neurocysticercosis. Antigens were prepared from the fluid, the protoscolex and the cyst wall of cysticerci dissected from infected pigs. The fluid antigen was tested both fresh and after freeze-drying and one year's storage. Sera from patients with proven neurocysticercosis were most reactive using the fluid and least reactive using the cyst wall antigens. Freeze-drying and prolonged storage of fluid antigen did not reduce its reactivity and repeated testing of sera with this antigen gave optical density values within 15% of the original value. Using this ELISA system positive results were obtained from all patients with active neurocysticercosis. Sera from patients with calcified cysts were usually non-reactive or marginally reactive to the fluid antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3188159     DOI: 10.1016/0035-9203(88)90451-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

Review 1.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Molecular characterization and diagnostic value of Taenia solium low-molecular-weight antigen genes.

Authors:  Y Sako; M Nakao; T Ikejima; X Z Piao; K Nakaya; A Ito
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  The relationship of antibody levels to the clinical spectrum of human neurocysticercosis.

Authors:  D Zini; V J Farrell; A A Wadee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

4.  Unusual cystic lesions of the spinal cord.

Authors:  G G Baily; M C Saddler
Journal:  J R Soc Med       Date:  1989-12       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.